HEPATIC VITAMIN A IN THE RAT AS AFFECTED BY THE ADMINISTRATION OF DIBENZANTHRACENE

Area of Science:

• Biochemistry
• Toxicology
• Nutritional Science

Background:

• Hepatotoxicity of polycyclic aromatic hydrocarbons (PAHs) is a significant concern.
• Vitamin A (retinol) is crucial for various physiological functions.
• Dibenzanthracene is a known carcinogen and PAH.

Purpose of the Study:

• To investigate the specific effects of dibenzanthracene on hepatic vitamin A metabolism in rats.
• To determine if dibenzanthracene causes general hepatic dysfunction.
• To explore the interaction between dibenzanthracene, vitamin A, and yeast in the liver.

Main Methods:

• Administration of dibenzanthracene to rats.
• Analysis of hepatic vitamin A concentrations.
• Assessment of liver functions including fat content, phospholipid levels, albumin synthesis, cholesterol esterification, glucuronic acid metabolism, and riboflavin storage.
• Evaluation of the effects of simultaneous yeast ingestion.

Main Results:

• Dibenzanthracene significantly decreased hepatic vitamin A concentrations.
• No evidence of general hepatic dysfunction was observed; key liver functions remained intact.
• Simultaneous ingestion of yeast further depleted hepatic vitamin A stores.
• Results suggest a competitive binding interaction between dibenzanthracene and vitamin A for a hepatic binding substance, possibly a protein.

Conclusions:

• Dibenzanthracene impairs hepatic vitamin A storage specifically, not through general liver damage.
• Yeast consumption exacerbates vitamin A depletion in the presence of dibenzanthracene.
• A potential competition for vitamin A binding sites in the liver is indicated.